Anti-inflammatory Pathways of Novel Anti-diabetic Therapies. A Literature Review
{{output}}
SGLT2 inhibitors (SGLT2is) and GLP-1 receptor agonists (GLP-1RAs) are two novel anti-diabetic therapeutic classes with an important impact on cardiovascular outcomes. Ongoing clinical trials are further investigating their potential beneficial effects on multi... ...
